Johnson & Johnson vs Novartis AG
Johnson & Johnson is worth $650.673B, 2.2× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $650.673B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $270.00 | $157.54 |
| Change | +3.93% | +1.90% |
| Revenue | $94.193B | $56.674B |
| Net income | $26.804B | $13.984B |
| Country | United States | Switzerland |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Johnson & Johnson bigger than Novartis AG?
- Johnson & Johnson has a market cap of $650.673B against $299.439B for Novartis AG, making it 2.2 times as valuable.
- Which company earns more, JNJ or NVS?
- Johnson & Johnson reported net income of $26.804B and Novartis AG reported $13.984B in their most recent annual periods.